CareLit · DOI-Nachweis · Klinische Pädiatrie
Transient apoptosis inhibition in hematopoietic stem and progenitor cells of donors increases efficacy of stem cell transplantation without increasing the risk of leukemogenesis
DOI 10.1055/s-0036-1582501
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Kollek, G Voigt, D Bertele, F Krombholz, N Fischer, C Niemeyer, S Geley, A Garcia-Saez, M Erlacher
ZeitschriftKlinische Pädiatrie
Ausgabe05/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: The only curative treatment for many hematological disorders is hematopoietic stem cell transplantation (HSCT) which unfortunately bears different transplantation-associated risks like graft failure or graft-versus-host disease. Since it is known that higher donor cell numbers accelerate the engraftment and lower the risk of graft failure, many experimental approaches aim to expand donor cell numbers e…
Zitieren
Zitierempfehlung
M Kollek, G Voigt, D Bertele, F Krombholz, N Fischer, C Niemeyer, S Geley, A Garcia-Saez, M Erlacher (2016) Transient apoptosis inhibition in hematopoietic stem and progenitor cells of donors increases efficacy of stem cell transplantation without increasing the risk of leukemogenesis. Klinische Pädiatrie (05). https://doi.org/10.1055/s-0036-1582501
Mit CareLit weiterarbeiten